What type of study is this?

This is a Quantitative Study study.

October 3, 2025Clinical ChemistryOpen Access

A-414 Assessment of the DCA Vantage and Atellica DCA HbA1c Dx Assays Compared to the European Reference Laboratory Method

View Full Paper

Ask AI

Bookmark

DCA Vantage and Atellica DCA HbA1c assays show strong correlation with the European Reference Laboratory method.
The DCA Vantage method yielded R2 of 0.9999 and the Atellica DCA method R2 of 0.9983 when correlated with ERL results.
Statistical analysis employed a linear mixed effects model and weighted-Deming regression to evaluate method comparisons.
Medical decision points for diabetes assessment align closely with observed prediction ranges from both DCA methods.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

This assessment compares HbA1c levels in patients using DCA Vantage and Atellica DCA methods against the European Reference Laboratory, suggesting high correlation.

Cite This Study

Yost et al. (2025) studied this question.

synapsesocial.com/papers/68e040e5a99c246f578b2f9f https://doi.org/10.1093/clinchem/hvaf086.398

View Full Paper

Ask AI

Bookmark

Implication

This assessment compares HbA1c levels in patients using DCA Vantage and Atellica DCA methods against the European Reference Laboratory, suggesting high correlation.

A-414 Assessment of the DCA Vantage and Atellica DCA HbA1c Dx Assays Compared to the European Reference Laboratory Method

Key Points

Discussion

Implication

Cite This Study

A-414 Assessment of the DCA Vantage and Atellica DCA HbA1c Dx Assays Compared to the European Reference Laboratory Method

Key Points

Discussion

Implication

Cite This Study

Keep reading

Keep reading